Industry

RemoniHealth Expands Hardware-Free ‘Vision-as-a-Service’ Platform for Remote Eyecare

Vision Monday1d ago1 min read

NEW YORK—RemoniHealth, a U.S.-based innovator in remote care management and AI-enabled ocular disease monitoring, announced it has expanded its proprietary Vision-as-a-Service (VaaS) platform through new, exclusive licensing arrangements. This expansion follows the completion of over 150,000 remote monitoring encounters using the platform, which is the first comprehensive Remote Patient Monitoring (RPM) and Principal Care Management (PCM) solution designed for eyecare, the announcement said. RemoniHealth said it added four powerful, clinically validated remote vision tests to its cloud-based VaaS ecosystem, expanding the platform to cover more than 90 percent of the U.S. population suffering from chronic, sight-threatening eye diseases—including dry AMD, wet AMD, glaucoma, diabetic retinopathy, dry eye, and various neuro-ophthalmic conditions.

Read full article on Vision Monday

AI Summary

Quick Take

RemoniHealth has expanded its hardware-free 'Vision-as-a-Service' (VaaS) platform by adding four clinically validated remote vision tests through new exclusive licensing deals. Following more than 150,000 successful remote encounters, the platform now provides a comprehensive Remote Patient Monitoring (RPM) solution for 90% of the U.S. population living with chronic conditions like AMD, glaucoma, and diabetic retinopathy.

Why It Matters

The shift toward remote patient monitoring is accelerating as clinics look for ways to manage high-volume chronic disease populations without overtaxing physical office space or staff. By utilizing a hardware-free, cloud-based model, RemoniHealth lowers the barrier to entry for both patients and providers compared to specialized, device-heavy home monitoring systems. This expansion signals a maturing of the 'Vision-as-a-Service' model, offering a scalable way to capture disease progression between scheduled visits while potentially opening new revenue streams through RPM and Principal Care Management (PCM) reimbursement codes.

Key Details

The platform is the first comprehensive Remote Patient Monitoring (RPM) and Principal Care Management (PCM) solution specifically designed for eyecare.
Expansion includes four new, clinically validated remote vision tests added to the existing cloud-based ecosystem via exclusive licensing.
The system is 'hardware-free,' meaning it does not require proprietary devices to be shipped to or maintained by the patient.
The platform has already logged over 150,000 remote monitoring encounters to date.
Disease coverage includes dry and wet AMD, glaucoma, diabetic retinopathy, dry eye, and neuro-ophthalmic conditions.

Practice Implications

Practice owners should evaluate how hardware-free RPM platforms can integrate into their existing workflow to monitor high-risk patients between office visits. Utilizing these tools may allow for earlier intervention during disease 'flares'—particularly in wet AMD and glaucoma—while providing a structured framework for billing PCM and RPM codes.

Who's Affected

OphthalmologistsOptometristsRetina SpecialistsGlaucoma SpecialistsPractice Owners

What's Next

Following this expansion, the industry should watch for increased integration of these remote tests into electronic health records (EHRs) to streamline clinical decision-making. Future developments will likely focus on refining AI-enabled monitoring to further automate the identification of sight-threatening changes across the platform's broad disease coverage.

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.